Patients affected by liver cirrhosis are at high risk for developing hepatocellular carcinoma (HCC). The aim of this study was to evaluate the feasibility of PIVKA-II (protein induced by vitamin K absence or antagonist-II) alone or in combination with α-1 fetoprotein (AFP), as a screening marker for development of HCC.
Diagnostic Accuracy of PIVKA-II, Alpha-Fetoprotein and a Combination of both in Diagnosis of Hepatocellular Carcinoma in Patients Affected by Chronic HCV Infection / Gentile, I., Buonomo, A.R., Scotto, R., Zappulo, E., Carriero, C., Piccirillo, M., Izzo, F., Rizzo, M., Cerasuolo, D., Borgia, G., Cavalcanti, E.. - In: IN VIVO. - ISSN 0258-851X. - 31:4(2017), p. 695-700.
Diagnostic Accuracy of PIVKA-II, Alpha-Fetoprotein and a Combination of both in Diagnosis of Hepatocellular Carcinoma in Patients Affected by Chronic HCV Infection
GENTILE, Ivan;BUONOMO, ANTONIO RICCARDO;SCOTTO, RICCARDO;ZAPPULO, EMANUELA;PICCIRILLO, MAURO;IZZO, FRANCESCO;BORGIA, GUGLIELMO;CAVALCANTI, Ernesta
2017
Abstract
Patients affected by liver cirrhosis are at high risk for developing hepatocellular carcinoma (HCC). The aim of this study was to evaluate the feasibility of PIVKA-II (protein induced by vitamin K absence or antagonist-II) alone or in combination with α-1 fetoprotein (AFP), as a screening marker for development of HCC.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
